Robotic versus open extended cholecystectomy for T1a-T3 gallbladder cancer: A matched comparison.
Robotic versus open extended cholecystectomy for T1a-T3 gallbladder cancer: A matched comparison.
复制标题
机器人与开放式扩大胆囊切除术治疗 T1a ~ T3 胆囊癌:匹配比较
DOI:
10.3389/fsurg.2022.1039828
复制
发表时间:
2022
影响因子:
1.8
通讯作者:
Wu, Linquan
中科院分区:
文献类型:
--
作者:
Yang, Jun;Li, Enliang;Wang, Cong;Luo, Shuaiwu;Fu, Zixuan;Peng, Jiandong;Liao, Wenjun;Wu, Linquan
关键词:
The feasibility and safety of robotic extended cholecystectomy (REC) are still uncertain. This study was performed to compare the short- and long-term outcomes of REC with those of open extended cholecystectomy (OEC) for T1a–T3 gallbladder cancer. From January 2015 to April 2022, 28 patients underwent REC in our center. To minimize any confounding factors, a 1:2 propensity score-matching analysis was conducted based on the patients’ demographics, liver function indicators, T stage, and symptoms. The data regarding demographics, perioperative outcomes, and long-term oncologic outcomes were reviewed. The visual analogue scale score was significantly lower in the REC than OEC group immediately postoperatively (3.68 ± 2.09 vs. 4.73 ± 1.85, P = 0.008), on postoperative day 1 (2.96 ± 1.75 vs. 3.69 ± 1.41, P = 0.023), and on postoperative day 2 (2.36 ± 1.55 vs. 2.92 ± 1.21, P = 0.031). In addition, the REC group exhibited a shorter time to first ambulation (P = 0.043), a shorter time to drainage tube removal (P = 0.038), and a shorter postoperative stay (P = 0.037), but hospital costs were significantly higher in the REC group (P < 0.001). However, no statistically significant difference was found in the operation time (P = 0.134), intraoperative blood loss (P = 0.467), or incidence of postoperative morbidity (P = 0.227) or mortality (P = 0.289) between the REC and OEC groups. In regard to long-term outcomes, the 3-year disease-free survival rate was comparable between the OEC and REC groups (43.1% vs. 57.2%, P = 0.684), as was the 3-year overall survival rate (62.8% vs. 75.0%, P = 0.619). REC can be an effective and safe alternative to OEC for selected patients with T1a–T3 gallbladder cancer with respect to short- and long-term outcomes.
登录
查看更多内容
影响因子:
3.7
作者:
Khan S;Beard RE;Kingham PT;Fong Y;Boerner T;Martinie JB;Vrochides D;Buell JF;Berber E;Kahramangil B;Troisi RI;Vanlander A;Molinari M;Tsung A
通讯作者:
Tsung A
影响因子:
5.9
作者:
Bae, Jae Seok;Kim, Se Hyung;Han, Joon Koo
通讯作者:
Han, Joon Koo
影响因子:
3.7
作者:
Chen, Po-Da;Wu, Chao-Ying;Wu, Yao-Ming
通讯作者:
Wu, Yao-Ming
DOI:
10.1007/s00464-012-2330-4
发表时间:
2012-11-01
影响因子:
3.1
作者:
Shen, Bai-Yong;Zhan, Qian;Li, Hong-Wei
通讯作者:
Li, Hong-Wei
影响因子:
9
作者:
Sasaki, Eiji;Nagino, Masato;Nimura, Yuji
通讯作者:
Nimura, Yuji